Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6236166 | 0.83 | THRB (0.34) | TDP1ATMMAPTLMNAALDH1A1 | |
| SCHEMBL5498682 | 0.82 | ELANE (0.32) | TDP1ATMELANEMAPTLMNA | |
| SCHEMBL6858822 | 0.79 | MAPT (0.41) | TDP1ATMELANEMAPTLMNA | |
| SCHEMBL19719089 | 0.77 | ELANE (0.31) | ELANE | |
| SCHEMBL17072632 | 0.75 | GAA (0.31) | MAPTLMNAALDH1A1MEN1KMT2A | |
| SCHEMBL11876274 | 0.74 | CYP2C19 (0.43) | TDP1ATMELANEMAPTALDH1A1 | |
| Styrene SCHEMBL4143998 | 0.74 | MAPT (0.37) | TDP1ATMELANEMAPTLMNA | |
| SCHEMBL28282211 | 0.74 | TDP1 (0.42) | TDP1ATMELANEMAPTLMNA | |
| SCHEMBL30075844 | 0.73 | ALDH1A1 (0.56) | ELANEMAPTLMNAALDH1A1CYP3A4 | |
| SCHEMBL11232755 | 0.73 | ALDH1A1 (0.56) | ELANEMAPTLMNAALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240019781-A1 | DISPERSION RESIN, PREPARATION METHOD THEREFOR AND PHOTORESIST COMPOSITION | Shenzhen Brthrborder Semiconductor Materials Co., Ltd. (CN) | 2024-01-18 | — | — | US | claimed |
| WO-2024085912-A1 | ADDITIVES FOR TONER PARTICLE CONTAINING POLYMER PARTICLES HAVING INTERPENETRATING POLYMER NETWORK | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-110412841-B | Toner and method for producing the same | 佳能株式会社 | 2024-04-16 | — | — | CN | disclosed |
| US-20240019781-A1 | DISPERSION RESIN, PREPARATION METHOD THEREFOR AND PHOTORESIST COMPOSITION | Shenzhen Brthrborder Semiconductor Materials Co., Ltd. (CN) | 2024-01-18 | — | — | US | disclosed |
| CN-107966878-B | Quantum dot-polymer composite film, method of manufacturing the same, and device including the same | 三星电子株式会社 | 2023-08-15 | — | — | CN | disclosed |
| CN-112105651-B | Method for producing disk-shaped polymer particles | 日清纺控股株式会社 | 2023-03-21 | — | — | CN | disclosed |
| US-20220096602-A1 | LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION | UNIV RUTGERS (US) | 2022-03-31 | — | — | US | disclosed |
| EP-2983657-B1 | NADOLOL FORMULATIONS FOR USE IN THE TREATMENT OF INFLAMMATORY BOWEL DISORDERS | NUMEDII INC (US) | 2020-06-03 | — | — | EP | disclosed |
| CN-110946867-A | Treatment of gastrointestinal and other disorders | 努梅迪公司 | 2020-04-03 | — | — | CN | disclosed |
| US-20160303133-A1 | TREATMENT OF GASTROINTESTINAL AND OTHER DISORDERS | NUMEDII, INC. (US) | 2016-10-20 | — | — | US | disclosed |
| EP-2983657-A1 | TREATMENT OF GASTROINTESTINAL AND OTHER DISORDERS | Numedii, Inc. (US) | 2016-02-17 | — | — | EP | disclosed |
| WO-2014165823-A1 | TREATMENT OF GASTROINTESTINAL AND OTHER DISORDERS | NUMEDII, INC. (US) | 2014-10-09 | — | — | WO | disclosed |
| EP-0390527-B1 | Toners for use in electrophotography and production thereof | BANDO CHEMICAL IND (JP) | 1996-02-21 | — | — | EP | disclosed |
| EP-0297839-B1 | A process for producing toners for use in electrophotography | BANDO CHEMICAL IND (JP) | 1995-04-05 | — | — | EP | disclosed |
| US-5328795-A | Suspension polymerization with color a monomer to form spheres | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 1994-07-12 | — | — | US | disclosed |
| EP-0390527-A2 | Toners for use in electrophotography and production thereof | BANDO CHEMICAL INDUSTRIES, LIMITED (JP) | 1990-10-03 | — | — | EP | disclosed |
| US-4904560-A | RADICAL POLYMERIZABLE MONOMER AND CARBON BLACK STIRRED WITH A PEROXIDE INITIATOR TO UNIFORMLY DISPERSE; ADDING AZOBISNITRILE TO POLYMERIZE | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 1990-02-27 | — | — | US | disclosed |
| EP-0297839-A2 | A process for producing toners for use in electrophotography | BANDO CHEMICAL INDUSTRIES, LIMITED (JP) | 1989-01-04 | — | — | EP | disclosed |
| US-4592990-A | Suspension polymerization of unsaturated monomer in aqueous solution | CANON KABUSHIKI KAISHA (JP) | 1986-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160303133-A1 | TREATMENT OF GASTROINTESTINAL AND OTHER DISORDERS | ADRB1, ADRB2, ADRA2B | TDP1 3451/4885ATM 4497/4885ELANE 1448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.